Sorry, no posts found.
- 2022 CRA Honorary Luncheon celebrating Dr. Michael Stevens
- CRA 18th Annual Meeting Registration NOW OPEN! Reserve your seat today!
- 2021 CRA Honorary Luncheon celebrating Dr. Daniel Furst
- CRA Webinar: Simplified Patient Screening Programs Can Reduce Diagnostic Delay in Non-radiographic Axial Spondyloarthritis (nr-axSpA)
- Manuscript with ORAL Surveillance Data Available in the New England Journal of Medicine January 27 Issue
- FDA Approval of Xeljanz (tofacitinib) for Ankylosing Spondylitis
- Abbvie receives FDA approval for Rinvoq to treat active Psoriatic Arthritis
- U.S. FDA Approves Cyltezo® (adalimumab-adbm) as First Interchangeable Biosimilar with Humira®
- CRA President, Dr. Samy Metyas featured in Capitol Weekly Op-Ed
- Anthem Clarifies Specialty Pharmacy Mandate
- CRA Issues Letters to California Business Advocacy Organizations Warning Them of Consequences of Anthem Blue Cross Mandate
- CRA Press Release – October 29, 2020 re: Anthem SPP Mandate
- ANTHEM’S SPECIALTY PHARMACY MANDATE
- Oxford University to Study Adalimumab as Potential COVID-19 Treatment